• Explore /
  • Poster
  • / Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and radioligand target quantitation: Preview of the Bladder BRIDGister.

Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and radioligand target quantitation: Preview of the Bladder BRIDGister.

Abstract Video & Slides Poster

Authors

null

Ralph M. Wirtz

STRATIFYER Molecular Pathology GmbH, Cologne, Germany

Ralph M. Wirtz , Paula Carolin Voss , Frank Friedersdorff , Dimitri Barski , Thomas Otto , Michael Waldner , Elke Veltrup , Friederike Linden , Meike Schwandt , Roland Hake , Sebastian Eidt , Jenny Roggisch , Constantin Rieger , Lucas Kastner , Axel Heidenreich , Stefan Koch , Richard P. Baum , Thorsten H Ecke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 543)

DOI

10.1200/JCO.2023.41.6_suppl.543

Abstract #

543

Poster Bd #

M6

Abstract Disclosures

Similar Posters

First Author: Ralph M. Wirtz

First Author: Florian Roghmann

First Author: Chiara Mercinelli

First Author: Patrick Squires